Literature DB >> 24532791

Conserved loop cysteines of vitamin K epoxide reductase complex subunit 1-like 1 (VKORC1L1) are involved in its active site regeneration.

Jian-Ke Tie1, Da-Yun Jin, Darrel W Stafford.   

Abstract

Vitamin K epoxide reductase complex subunit 1 (VKORC1) reduces vitamin K epoxide in the vitamin K cycle for post-translational modification of proteins that are involved in a variety of biological functions. However, the physiological function of VKORC1-like 1 (VKORC1L1), a paralogous enzyme sharing about 50% protein identity with VKORC1, is unknown. Here we determined the structural and functional differences of these two enzymes using fluorescence protease protection (FPP) assay and an in vivo cell-based activity assay. We show that in vivo VKORC1L1 reduces vitamin K epoxide to support vitamin K-dependent carboxylation as efficiently as does VKORC1. However, FPP assays show that unlike VKORC1, VKORC1L1 is a four-transmembrane domain protein with both its termini located in the cytoplasm. Moreover, the conserved loop cysteines, which are not required for VKORC1 activity, are essential for VKORC1L1's active site regeneration. Results from domain exchanges between VKORC1L1 and VKORC1 suggest that it is VKORC1L1's overall structure that uniquely allows for active site regeneration by the conserved loop cysteines. Intermediate disulfide trapping results confirmed an intra-molecular electron transfer pathway for VKORC1L1's active site reduction. Our results allow us to propose a concerted action of the four conserved cysteines of VKORC1L1 for active site regeneration; the second loop cysteine, Cys-58, attacks the active site disulfide, forming an intermediate disulfide with Cys-139; the first loop cysteine, Cys-50, attacks the intermediate disulfide resulting in active site reduction. The different membrane topologies and reaction mechanisms between VKORC1L1 and VKORC1 suggest that these two proteins might have different physiological functions.

Entities:  

Keywords:  Disulfide; Electron Transfer; Endoplasmic Reticulum (ER); Enzymes; Membrane Proteins; Post-translational Modification; Protein Carboxylation; Vitamin K

Mesh:

Substances:

Year:  2014        PMID: 24532791      PMCID: PMC3979397          DOI: 10.1074/jbc.M113.534446

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Mycobacterium tuberculosis vitamin K epoxide reductase homologue supports vitamin K-dependent carboxylation in mammalian cells.

Authors:  Jian-Ke Tie; Da-Yun Jin; Darrel W Stafford
Journal:  Antioxid Redox Signal       Date:  2011-11-22       Impact factor: 8.401

2.  A guideline to proteome-wide α-helical membrane protein topology predictions.

Authors:  Konstantinos D Tsirigos; Aron Hennerdal; Lukas Käll; Arne Elofsson
Journal:  Proteomics       Date:  2012-08       Impact factor: 3.984

Review 3.  Prediction of warfarin dose: why, when and how?

Authors:  Niclas Eriksson; Mia Wadelius
Journal:  Pharmacogenomics       Date:  2012-03       Impact factor: 2.533

4.  Consensus predictions of membrane protein topology.

Authors:  J Nilsson; B Persson; G von Heijne
Journal:  FEBS Lett       Date:  2000-12-15       Impact factor: 4.124

5.  A new cell culture-based assay quantifies vitamin K 2,3-epoxide reductase complex subunit 1 function and reveals warfarin resistance phenotypes not shown by the dithiothreitol-driven VKOR assay.

Authors:  A Fregin; K J Czogalla; J Gansler; S Rost; M Taverna; M Watzka; C G Bevans; C R Müller; J Oldenburg
Journal:  J Thromb Haemost       Date:  2013-05       Impact factor: 5.824

6.  Evaluation of warfarin resistance using transcription activator-like effector nucleases-mediated vitamin K epoxide reductase knockout HEK293 cells.

Authors:  J-K Tie; D-Y Jin; K Tie; D W Stafford
Journal:  J Thromb Haemost       Date:  2013-08       Impact factor: 5.824

Review 7.  Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization.

Authors:  Leon J Schurgers; Jouni Uitto; Chris P Reutelingsperger
Journal:  Trends Mol Med       Date:  2013-01-30       Impact factor: 11.951

8.  Human vitamin K epoxide reductase and its bacterial homologue have different membrane topologies and reaction mechanisms.

Authors:  Jian-Ke Tie; Da-Yun Jin; Darrel W Stafford
Journal:  J Biol Chem       Date:  2012-08-24       Impact factor: 5.157

9.  VKORC1L1, an enzyme rescuing the vitamin K 2,3-epoxide reductase activity in some extrahepatic tissues during anticoagulation therapy.

Authors:  Abdessalem Hammed; Benjamin Matagrin; Gabriele Spohn; Caroline Prouillac; Etienne Benoit; Virginie Lattard
Journal:  J Biol Chem       Date:  2013-08-08       Impact factor: 5.157

10.  Polymorphisms in VKORC1 have more impact than CYP2C9 polymorphisms on early warfarin International Normalized Ratio control and bleeding rates.

Authors:  Kirstin Lund; Dairena Gaffney; Richard Spooner; Anne Marie Etherington; Patrick Tansey; Robert Campbell Tait
Journal:  Br J Haematol       Date:  2012-05-10       Impact factor: 6.998

View more
  18 in total

1.  Characterization of Warfarin Inhibition Kinetics Requires Stabilization of Intramembrane Vitamin K Epoxide Reductases.

Authors:  Shuang Li; Shixuan Liu; Yihu Yang; Weikai Li
Journal:  J Mol Biol       Date:  2020-05-20       Impact factor: 5.469

Review 2.  Chemistry and Enzymology of Disulfide Cross-Linking in Proteins.

Authors:  Deborah Fass; Colin Thorpe
Journal:  Chem Rev       Date:  2017-07-12       Impact factor: 60.622

3.  VKOR paralog VKORC1L1 supports vitamin K-dependent protein carboxylation in vivo.

Authors:  Julie Lacombe; Mark A Rishavy; Kathleen L Berkner; Mathieu Ferron
Journal:  JCI Insight       Date:  2018-01-11

4.  Stabilization of warfarin-binding pocket of VKORC1 and VKORL1 by a peripheral region determines their different sensitivity to warfarin inhibition.

Authors:  G Shen; S Li; W Cui; S Liu; Q Liu; Y Yang; M Gross; W Li
Journal:  J Thromb Haemost       Date:  2018-05-20       Impact factor: 5.824

5.  Intramembrane Thiol Oxidoreductases: Evolutionary Convergence and Structural Controversy.

Authors:  Shuang Li; Guomin Shen; Weikai Li
Journal:  Biochemistry       Date:  2017-11-07       Impact factor: 3.162

6.  Zebrafish vitamin K epoxide reductases: expression in vivo, along extracellular matrix mineralization and under phylloquinone and warfarin in vitro exposure.

Authors:  Ignacio Fernández; Parameswaran Vijayakumar; Carlos Marques; M Leonor Cancela; Paulo J Gavaia; Vincent Laizé
Journal:  Fish Physiol Biochem       Date:  2015-03-20       Impact factor: 2.794

7.  Warfarin traps human vitamin K epoxide reductase in an intermediate state during electron transfer.

Authors:  Guomin Shen; Weidong Cui; Hao Zhang; Fengbo Zhou; Wei Huang; Qian Liu; Yihu Yang; Shuang Li; Gregory R Bowman; J Evan Sadler; Michael L Gross; Weikai Li
Journal:  Nat Struct Mol Biol       Date:  2016-12-05       Impact factor: 15.369

8.  Association of Warfarin Use With Lower Overall Cancer Incidence Among Patients Older Than 50 Years.

Authors:  Gry S Haaland; Ragnhild S Falk; Oddbjørn Straume; James B Lorens
Journal:  JAMA Intern Med       Date:  2017-12-01       Impact factor: 21.873

9.  VKORC1 and VKORC1L1 have distinctly different oral anticoagulant dose-response characteristics and binding sites.

Authors:  Katrin J Czogalla; Kerstin Liphardt; Klara Höning; Veit Hornung; Arijit Biswas; Matthias Watzka; Johannes Oldenburg
Journal:  Blood Adv       Date:  2018-03-27

Review 10.  Structural and functional insights into enzymes of the vitamin K cycle.

Authors:  J-K Tie; D W Stafford
Journal:  J Thromb Haemost       Date:  2016-01-29       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.